Aurinia Pharmaceuticals Inc (AUPH) — Long-term Investment Intensity
Aurinia Pharmaceuticals Inc (AUPH) has a Long-term Investment Intensity of 0.0% as of June 2024. Long-term investments of $199.00K represent 0.0% of total assets of $523.53 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Aurinia Pharmaceuticals Inc (AUPH) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Aurinia Pharmaceuticals Inc Long-term Investment Intensity (2020–2023)
This chart shows how Aurinia Pharmaceuticals Inc's Long-term Investment Intensity has evolved across 2 annual periods from 2020 to 2023. As of June 2024, the intensity stands at 0.0%, reflecting long-term investments of $199.00K against total assets of $523.53 Million USD. Explore AUPH operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Aurinia Pharmaceuticals Inc (2020–2023)
The table below presents the year-by-year Long-term Investment Intensity for Aurinia Pharmaceuticals Inc from 2020 to 2023, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Aurinia Pharmaceuticals Inc (AUPH) total market value.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2023 | 0.0% | $201.00K | $548.06 Million | ▼ -5.2 pp |
| 2020 | 5.3% | $24.38 Million | $463.66 Million | — |